$229.650
-2.962 (-1.29%)收盤時
STE 資訊
STE 事件
Steris Invests $600M to Build Manufacturing Center in North Carolina
Steris announced that it will be investing $600M to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub to produce high-performance infection prevention and contamination control chemistries used across the Healthcare and Pharmaceutical industries.
Steris Announces Quarterly Dividend of 69 Cents per Share
Steris announced that the company will distribute a quarterly interim dividend of 69c per share. This represents a 6c increase in the dividend. The dividend is payable on September 25 to shareholders of record at the close of business on September 4.
Sees FY27 Revenue Growth 7%-8% from $5.9B
Sees FY27 revenue growth 7%-8% from $5.9B, consensus $6.31B. Sees FY27 CapEx $375M.
Company Reports Q4 Revenue of $1.6B
Reports Q4 revenue $1.6B, consensus $1.6B. "FY26 was another record year," said CEO Dan Carestio. "Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associates who continue to put our Customers first. As we look ahead, we are excited for what is to come as we capitalize on our unique ability to help our Customers enable procedural growth, deliver quality outcomes and drive compliance with standardization and optimization."
Company Expects 8-9% Revenue Growth for Fiscal 2026
For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 8-9%, and constant currency organic revenue from continuing operations growth of 7-8%.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。